Found: 12
Select item for more details and to access through your institution.
Overcoming resistance to anabolic SARM therapy in experimental cancer cachexia with an HDAC inhibitor.
- Published in:
- EMBO Molecular Medicine, 2020, v. 12, n. 2, p. N.PAG, doi. 10.15252/emmm.201809910
- By:
- Publication type:
- Article
Constitutively Active Androgen Receptor in Hepatocellular Carcinoma.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 22, p. 13768, doi. 10.3390/ijms232213768
- By:
- Publication type:
- Article
The Neonatal Fc Receptor Is Elevated in Monocyte-Derived Immune Cells in Pancreatic Cancer.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 13, p. 7066, doi. 10.3390/ijms23137066
- By:
- Publication type:
- Article
Selective androgen receptor modulators for the treatment of late onset male hypogonadism.
- Published in:
- Asian Journal of Andrology, 2014, v. 16, n. 2, p. 256, doi. 10.4103/1008-682X.122339
- By:
- Publication type:
- Article
Discovery and Preclinical Characterization of Novel Small Molecule TRK and ROS1 Tyrosine Kinase Inhibitors for the Treatment of Cancer and Inflammation.
- Published in:
- PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0083380
- By:
- Publication type:
- Article
A phase 1 trial of the histone deacetylase inhibitor AR-42 in patients with neurofibromatosis type 2-associated tumors and advanced solid malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 87, n. 5, p. 599, doi. 10.1007/s00280-020-04229-3
- By:
- Publication type:
- Article
Inhibition of androgen/AR signaling inhibits diethylnitrosamine (DEN) induced tumour initiation and remodels liver immune cell networks.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-82252-x
- By:
- Publication type:
- Article
Role and pharmacologic significance of cytochrome P-450 2D6 in oxidative metabolism of toremifene and tamoxifen.
- Published in:
- International Journal of Cancer, 2013, v. 132, n. 6, p. 1475, doi. 10.1002/ijc.27794
- By:
- Publication type:
- Article
Preclinical Evaluation of the Novel BTK Inhibitor Acalabrutinib in Canine Models of B-Cell Non-Hodgkin Lymphoma.
- Published in:
- PLoS ONE, 2016, v. 11, n. 7, p. 1, doi. 10.1371/journal.pone.0159607
- By:
- Publication type:
- Article
Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.857590
- By:
- Publication type:
- Article
Murine cancer cachexia models replicate elevated catabolic pembrolizumab clearance in humans.
- Published in:
- JCSM Rapid Communications, 2021, v. 4, n. 2, p. 232, doi. 10.1002/rco2.32
- By:
- Publication type:
- Article
Target specificity, in vivo pharmacokinetics, and efficacy of the putative STAT3 inhibitor LY5 in osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma.
- Published in:
- PLoS ONE, 2017, v. 12, n. 7, p. 1, doi. 10.1371/journal.pone.0181885
- By:
- Publication type:
- Article